Differential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas

PLoS ONE

Volumn 2, Issue 4, 2007, Pages

  Kothapalli, Kumar S D ^a   Anthony, Joshua C ^b   Pan, Bruce S ^a   Hsieh, Andrea T ^a   Nathanielsz, Peter W ^c   Brenna, J Thomas ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Mead Johnson Nutritionals   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LONG CHAIN FATTY ACID; LUMICAN; MITOCHONDRIAL PROTEIN; PHOSPHOLIPASE; PLA2G6 PROTEIN; POLYUNSATURATED FATTY ACID; TIMMA8A PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTOME; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ARTIFICIAL MILK; BABOON; BRAIN CORTEX; CELL ADHESION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REGULATORY NETWORK; INFANT NUTRITION; LIPID METABOLISM; LIPID TRANSPORT; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; RNA TRANSLATION; SIGNAL TRANSDUCTION; UPREGULATION; VISUAL ACUITY; ANIMAL; GENETICS; METABOLISM; VISION;

ARA; PAPIO; PRIMATES;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL ADHESION; CEREBRAL CORTEX; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GTP-BINDING PROTEINS; PAPIO; SIGNAL TRANSDUCTION; VISUAL PERCEPTION;

EID: 34548431107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000370     Document Type: Article

References (188)

1. Crawford MA, Casperd NM, Sinclair AJ (1976) The long chain metabolites of linoleic avid linolenic acids in liver and brain in herbivores and carnivores. Comp Biochem Physiol B 54: 395-401.
2. Diau GY, Hsieh AT, Sarkadi-Nagy EA, Wijendran V, Nathanielsz PW, et al. (2005) The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med 3: 11.
3. Benolken RM, Anderson RE, Wheeler TG (1973) Membrane fatty acids associated with the electrical response in visual excitation. Science 182: 1253-1254.
4. Martinez M (1992) Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120: S129-138.
5. Morale SE, Hoffman DR, Castaneda YS, Wheaton DH, Burns RA, et al. (2005) Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev 81: 197-203.
6. Marszalek JR, Lodish HE (2005) Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: Breastmilk and fish are good for you. Annual Review of Cell and Developmental Biology 21: 633-657.
7. Brenna JT (2002) Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 5: 127-132.
8. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, et al. (2006) Docosahexaenoic and arachidonic acid concentrations in human breastmilks worldwide. Pediatrics submitted.
9. Innis SM, Kuhnlein HV (1988) Long-Chain N-3 Fatty-Acids in Breast-Milk of Inuit Women Consuming Traditional Foods. Early Human Development 18: 185-189.
10. Finley DA, Lonnerdal B, Dewey KG, Grivetti LE (1985) Breast milk composition: fat content and fatty acid composition in vegetarians and non-vegetarians. Am J Clin Nutr 41: 787-800.
11. Wang L, Shimizu Y, Kaneko S, Hanaka S, Abe T, et al. (2000) Comparison of the fatty acid composition of total lipids and phospholipids in breast milk from Japanese women. Pediatr Int 42: 14-20.
12. Makrides M, Neumann MA, Gibson RA (1996) Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 50: 352-357.
13. Lauritzen L, Jorgensen MH, Hansen HS, Michaelsen KF (2002) Fluctuations in human milk long-chain PUFA levels in relation to dietary fish intake. Lipids 37: 237-244.
14. Jensen CL, Prager TC, Fraley JK, Chen HM, Anderson RE, et al. (1997) Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants. Journal of Pediatrics 131: 200-209.
15. Makrides M, Neumann MA, Jeffrey B, Lien EL, Gibson RA (2000) A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: effects on visual function and growth. American Journal of Clinical Nutrition 71: 120-129.
16. Gibson RA, Chen W, Makrides M (2001) Randomized trials with polyunsaturated fatty acid interventions in preterm and term infants: functional and clinical outcomes. Lipids 36: 873-883.
17. Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M (1998) Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352: 688-691.
18. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG (2000) A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Developmental Medicine and Child Neurology 42: 174-181.
19. Birch EE, Castaneda YS, Wheaton DH, Birch DG, Uauy RD, et al. (2005) Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. American Journal of Clinical Nutrition 81: 871-879.
20. Clandinin MT, Van Aerde JE, Merkel KL, Harris CL, Springer MA, et al. (2005) Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. Journal of Pediatrics 146: 461-468.
21. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, et al. (1980) Intrauterine Fatty-Acid Accretion Rates in Human-Brain-Implications for Fatty-Acid Requirements. Early Human Development 4: 121-129.
22. Martinez M, Mougan I (1998) Fatty acid composition of human brain phospholipids during normal development. Journal of Neurochemistry 71: 2528-2533.
23. Lauritzen L, Jorgensen MH, Olsen SF, Straarup EM, Michaelsen KF (2005) Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reproduction Nutrition Development 45: 535-547.
24. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, et al. (1980) Extra-Uterine Fatty-Acid Accretion in Infant Brain-Implications for Fatty-Acid Requirements. Early Human Development 4: 131-138.
25. Treen M, Uauy RD, Jameson DM, Thomas VL, Hoffman DR (1992) Effect of Docosahexaenoic Acid on Membrane Fluidity and Function in Intact Cultured Y-79 Retinoblastoma Cells. Archives of Biochemistry and Biophysics 294: 564-570.
26. Kitajka K, Sinclair AJ, Weisinger RS, Weisinger HS, Mathai M, et al. (2004) Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proceedings of the National Academy of Sciences of the United States of America 101: 10931-10936.
27. Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, et al. (2004) Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reproduction Nutrition Development 44: 509-538.
28. Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassall SR (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reproduction Nutrition Development 45: 559-579.
29. Grossfield A, Feller SE, Pitman MC (2006) A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc Natl Acad Sci U S A 103: 4888-4893.
30. Calderon F, Kim HY (2004) Docosahexaenoic acid promotes neurite growth in hippocampal neurons. Journal of Neurochemistry 90: 979-988.
31. Clarke SD, Jump DB (1994) Dietary polyunsaturated fatty acid regulation of gene transcription. Annu Rev Nutr 14: 83-98.
32. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH (1993) Growth in utero and serum cholesterol concentrations in adult life. Bmj 307: 1524-1527.
33. de Rooij SR, Painter RC, Roseboom TJ, Phillips DI, Osmond C, et al. (2006) Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 49: 637-643.
34. Barker DJ (2003) Coronary heart disease: a disorder of growth. Horm Res 59 Suppl 1: 35-41.
35. Weisinger HS, Armitage JA, Sinclair AJ, Vingrys AJ, Burns PL, et al. (2001) Perinatal omega-3 fatty acid deficiency affects blood pressure later in life. Nat Med 7: 258-259.
36. Baur LA, O'Connor J, Pan DA, Kriketos AD, Storlien LH (1998) The fatty acid composition of skeletal muscle membrane phospholipid: its relationship with the type of feeding and plasma glucose levels in young children. Metabolism 47: 106-112.
37. Sarkadi-Nagy E, Wijendran V, Diau GY, Chao AC, Hsieh AT, et al. (2004) Formula feeding potentiates docosahexaenoic and arachidonic acid biosynthesis in term and preterm baboon neonates. J Lipid Res 45: 71-80.
38. Hsieh AT, Anthony JC, Diersen-Schade DA, Rumsey SC, Lawrence P, et al. (2007) The influence of moderate and high dietary docosahexanoic acid on baboon neonate neural fatty acids. Ped Res In Press.
39. Morgan NV, Westaway SK, Morton JE, Gregory A, Gissen P, et al. (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38: 752-754.
40. Khateeb S, Flusser H, Ofir R, Shelef I, Narkis G, et al. (2006) PLA2G6 Mutation Underlies Infantile Neuroaxonal Dystrophy. Am J Hum Genet 79: 942-948.
41. Leonard AE, Bobik EG, Dorado J, Kroeger PE, Chuang LT, et al. (2000) Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids. Biochem J 350 Pt 3: 765-770.
42. Leonard AE, Kelder B, Bobik EG, Chuang LT, Lewis CJ, et al. (2002) Identification and expression of mammalian long-chain PUFA elongation enzymes. Lipids 37: 733-740.
43. Welsch DJ, Creely DP, Hauser SD, Mathis KJ, Krivi GG, et al. (1994) Molecular cloning and expression of human leukotriene-C4 synthase. Proc Natl Acad Sci U S A 91: 9745-9749.
44. Buchner J (1999) Hsp90&Co.-a holding for folding. Trends Biochem Sci 24: 136-141.
45. Weaver AJ, Sullivan WP, Felts SJ, Owen BA, Toft DO (2000) Crystal structure and activity of human p23, a heat shock protein 90 co-chaperone. J Biol Chem 275: 23045-23052.
46. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, et al. (1999) Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 13: 817-826.
47. Rozen R, Vockley J, Zhou L, Milos R, Willard J, et al. (1994) Isolation and expression of a cDNA encoding the precursor for a novel member (ACADSB) of the acyl-CoA dehydrogenase gene family. Genomics 24: 280-287.
48. Ye X, Ji C, Zhou C, Zeng L, Gu S, et al. (2004) Cloning and characterization of a human cDNA ACAD10 mapped to chromosome 12q24.1. Mol Biol Rep 31: 191-195.
49. Mawal YR, Qureshi IA (1994) Purification to homogeneity of mitochondrial acyl coa:glycine n-acyltransferase from human liver. Biochem Biophys Res Commun 205: 1373-1379.
50. Mawal Y, Paradis K, Qureshi IA (1997) Developmental profile of mitochondrial glycine N-acyltransferase in human liver. J Pediatr 130: 1003-1007.
51. Waterham HR, Koster J, Romeijn GJ, Hennekam RC, Vreken P, et al. (2001) Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69: 685-694.
52. Peri A, Danza G, Serio M (2005) Seladin-1 as a target of estrogen receptor activation in the brain: a new gene for a rather old story? J Endocrinol Invest 28: 285-293.
53. Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Franceschi E, et al. (2005) Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. J Clin Endocrinol Metab 90: 1775-1782.
54. Evans AM (2006) AMP-activated protein kinase and the regulation of Ca2+ signalling in O2-sensing cells. J Physiol.
55. Watt MJ, Dzamko N, Thomas WG, Rose-John S, Ernst M, et al. (2006) CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 12: 541-548.
56. Dyck JR, Lopaschuk GD (2006) AMPK alterations in cardiac physiology and pathology: enemy or Ally? J Physiol.
57. Miyazaki A, Kanome T, Watanabe T (2005) Inhibitors of acyl-coenzyme a: cholesterol acyltransferase. Curr Drug Targets Cardiovasc Haematol Disord 5: 463-469.
58. Stein O, Stein Y (2005) Lipid transfer proteins (LTP) and atherosclerosis. Atherosclerosis 178: 217-230.
59. Leon C, Hill JS, Wasan KM (2005) Potential role of acyl-coenzyme A : cholesterol transferase (ACAT) inhibitors as hypolipidemic and antiatherosclerosis drugs. Pharmaceutical Research 22: 1578-1588.
60. Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, et al. (1998) A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18: 219-224.
61. Mullenbach R, Bennett A, Tetlow N, Patel N, Hamilton G. et al. (2005) ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 54: 829-834.
62. Liu H, Maurice DH (1998) Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP. Br J Pharmacol 125: 1501-1510.
63. Ding B, Abe J, Wei H, Huang Q, Walsh RA, et al. (2005) Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure. Circulation 111: 2469-2476.
64. Kuthe A, Magert H, Uckert S, Forssmann WG, Stief CG, et al. (2000) Gene expression of the phosphodiesterases 3A and 5A in human corpus cavernosum penis. Eur Urol 38: 108-114.
65. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
66. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, et al. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546.
67. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532.
68. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG (1996) Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98: 1101-1106.
69. Baillie RA, Takada R, Nakamura M, Clarke SD (1999) Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition. Prostaglandins Leukot Essent Fatty Acids 60: 351-356.
70. Hun CS, Hasegawa K, Kawabata T, Kato M, Shimokawa T, et al. (1999) Increased uncoupling protein2 mRNA in white adipose tissue, and decrease in leptin, visceral fat, blood glucose, and cholesterol in KK-Ay mice fed with eicosapentaenoic and docosahexaenoic acids in addition to linolenic acid. Biochem Biophys Res Commun 259: 85-90.
71. Mattiasson G, Sullivan PG (2006) The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal 8: 1-38.
72. Sullivan PG, Dube C, Dorenbos K, Steward O, Baram TZ (2003) Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol 53: 711-717.
73. Blachly-Dyson E, Baldini A, Litt M, McCabe ER, Forte M (1994) Human genes encoding the voltage-dependent anion channel (VDAC) of the outer mitochondrial membrane: mapping and identification of two new isoforms. Genomics 20: 62-67.
74. Shafir I, Feng W, Shoshan-Barmataz V (1998) Voltage-dependent anion channel proteins in synaptosomes of the torpedo electric organ: immunolocalization, purification, and characterization. J Bioenerg Biomembr 30: 499-510.
75. Massa R, Marliera LN, Martorana A, Cicconi S, Pierucci D, et al. (2000) Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle. J Muscle Res Cell Motil 21: 433-442.
76. Sampson MJ, Decker WK, Beaudet AL, Ruitenbeek W, Armstrong D, et al. (2001) Immotile sperm and infertility in mice lacking mitochondrial voltage-dependent anion channel type 3. J Biol Chem 276: 39206-39212.
77. Percy ME, Wong S, Bauer S, Liaghati-Nasseri N, Perry MD, et al. (1998) Iron metabolism and human ferritin heavy chain cDNA from adult brain with an elongated untranslated region: new findings and insights. Analyst 123: 41-50.
78. Salem N Jr, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36: 945-959.
79. Bomsel M, Mostov K (1992) Role of heterotrimeric G proteins in membrane traffic. Mol Biol Cell 3: 1317-1328.
80. Offermanns S, Mancino V, Revel JP, Simon MI (1997) Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275: 533-536.
81. Liu AM, Wong YH (2005) Activation of nuclear factor {kappa}B by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves G{alpha}14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src. J Biol Chem 280: 34617-34625.
82. Usdin TB, Gruber C, Bonner TI (1995) Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270: 15455-15458.
83. Usdin TB, Wang T, Hoare SR, Mezey E, Palkovits M (2000) New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues. Front Neuroendocrinol 21: 349-383.
84. Harzenetter MD, Keller U, Beer S, Riedl C, Peschel C, et al. (2002) Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp Hematol 30: 306-312.
85. Tissir F, Goffinet AM (2006) Expression of planar cell polarity genes during development of the mouse CNS. Eur J Neurosci 23: 597-607.
86. Tatemoto K (1982) Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A 79: 5485-5489.
87. Gehlert DR (1998) Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc Soc Exp Biol Med 218: 7-22.
88. Pedrazzini T, Seydoux J, Kunstner P, Aubert JF, Grouzmann E, et al. (1998) Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4: 722-726.
89. Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, et al. (1999) Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 274: 27776-27785.
90. Senderek J, Bergmann C, Stendel C, Kirfel J, Verpoorten N, et al. (2003) Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet 73: 1106-1119.
91. Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR (2004) Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). J Med Genet 41: 837-841.
92. Kuorilehto T, Ekholm E, Nissinen M, Hietaniemi K, Hiltunen A, et al. (2006) NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem 54: 363-370.
93. Vasiliauskas D, Hancock S, Stern CD (1999) SWiP-1: novel SOCS box containing WD-protein regulated by signalling centres and by Shh during development. Mech Dev 82: 79-94.
94. Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, et al. (2004) Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem 279: 31098-31104.
95. Litman BJ, Niu SL, Polozova A, Mitchell DC (2001) The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J Mol Neurosci 16: 237-242; discussion 279-284.
96. Mitchell DC, Niu SL, Litman BJ (2001) Optimization of receptor-G protein coupling by bilayer lipid composition I: kinetics of rhodopsin-transducin binding. J Biol Chem 276: 42801-42806.
97. Niu SL, Mitchell DC, Litman BJ (2001) Optimization of receptor-G protein coupling by bilayer lipid composition II: formation of metarhodopsin II-transducin complex. J Biol Chem 276: 42807-42811.
98. Tranebjaerg L, Hamel BCJ, Gabreels FJM, Renier WO, Van Ghelue M (2000) A de novo missense mutation in a critical domain of the X-linked DDP gene causes the typical deafness-dystonia-optic atrophy syndrome. European Journal of Human Genetics 8: 464-467.
99. Hofmann S, Rothbauer U, Muhlenbein N, Neupert W, Gerbitz KD, et al. (2002) The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1 center dot TIM13 complexes in the mitochondrial intermembrane space. Journal of Biological Chemistry 277: 23287-23293.
100. Tranebjaerg L, Jensen PK, Van Ghelue M, Vnencak-Jones CL, Sund S, et al. (2001) Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene. Ophthalmic Genet 22: 207-223.
101. Bernstein HG, Lendeckel U, Bertram I, Bukowska A, Kanakis D, et al. (2006) Localization of neuregulin-1alpha (heregulin-alpha) and one of its receptors, ErbB-4 tyrosine kinase, in developing and adult human brain. Brain Res Bull 69: 546-559.
102. Lopez-Bendito G, Cautinat A, Sanchez JA, Bielle F, Flames N, et al. (2006) Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell 125: 127-142.
103. Dooley CM, James J, McGlade CJ, Ahmad I (2003) Involvement of Numb in vertebrate retinal development: Evidence for multiple roles of Numb in neural differentiation and maturation. Journal of Neurobiology 54: 313-325.
104. Ishibashi M, Moriyoshi K, Sasai Y, Shiota K, Nakanishi S, et al. (1994) Persistent Expression of Helix-Loop-Helix Factor Hes-1 Prevents Mammalian Neural Differentiation in the Central-Nervous-System. Embo Journal 13: 1799-1805.
105. Carlson EC, Liu CY, Chikama TI, Hayashi Y, Kao CWC, et al. (2005) Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican. Journal of Biological Chemistry 280: 25541-25547.
106. Chakravarti S, Magnuson T (1995) Localization of Mouse Lumican (Keratan Sulfate Proteoglycan) to Distal Chromosome lo. Mammalian Genome 6: 367-368.
107. Beecher N, Chakravarti S, Joyce S, Meek KM, Quantock AJ (2006) Neonatal development of the corneal stroma in wild-type and lumican-null mice. Invest Ophthalmol Vis Sci 47: 146-150.
108. Quantock AJ, Meek KM, Chakravarti S (2001) An X-ray diffraction investigation of corneal structure in lumican-deficient mice. Investigative Ophthalmology&Visual Science 42: 1750- 1756.
109. Li Z, Clarke MP, Barker MD, McKie N (2005) TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights. Expert-Rev Mol Med 7: 1-15.
110. Clarke M, Mitchell KW, Goodship J, McDonnell S, Barker MD, et al. (2001) Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism. British Journal of Ophthalmology 85: 1429-1431.
111. Kuehn MH, Hageman GS (1999) Expression and characterization of the IPM 150 gene (IMPG1) product, a novel human photoreceptor cell-associated chondroitin-sulfate proteoglycan. Matrix Biology 18: 509-518.
112. Mathers PH, Jarmich M (2000) Regulation of eye formation by the Rx and pax6 homeobox genes. Cellular and Molecular Life Sciences 57: 186-194.
113. Furukawa T, Mukherjee S, Bao ZZ, Morrow EM, Cepko CL (2000) tax, hes1, and notch1 promote the formation of Muller glia by postnatal retinal progenitor cells. Neuron 26: 383-394.
114. Leifert WR, Jahangiri A, McMurchie EJ (2000) Membrane fluidity changes are associated with the antiarrhythmic effects of docosahexaenoic acid in adult rat cardionmocytes. Journal of Nutritional Biochemistry 11: 38-44.
115. Stillwell W, Wassall SR (2003) Docosahexacnoic acid: membrane properties of a unique fatty acid. Chemistry and Physics of Lipids 126: 1-27.
116. SanGiovanni JP, Chew EY (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in Retinal and Eye Research 24: 87-138.
117. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, et al. (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32: 579-581.
118. Davy BE, Robinson ML (2003) Congenital hydrocephalus in hy3 mice is caused by a frameshift mutation in Hydin, a large novel gene. Human Molecular Genetics 12: 1163-1170.
119. Yu S, Hao Y, Lowe AW (2004) Effects of GP2 expression on secretion and endocytosis in pancreatic AR4-2J cells. Biochemical and Biophysical Research Communications 322: 320-325.
120. Kuida K, Zheng TS, Na SQ Kuan CY, Yang D, et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372.
121. Jacobson MD, Weil M, Raff MC (1997) Programmed cell death in animal development. Cell 88: 347-354.
122. Dufner A, Pownall S, Mak TW (2006) Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation. Proc Natl Acad Sci U S A 103: 988-993.
123. Narayanan BA, Narayanan NK, Reddy BS (2001) Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 19: 1255-1262.
124. Dixon DA, Balch GC, Kedersha N, Anderson P, Zimmerman GA, et al. (2003) Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. Journal of Experimental Medicine 198: 475-481.
125. Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, But G, et al. (2002) Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). Journal of Biological Chemistry 277: 11772-11779.
126. Brady SC, Allan LA, Clarke PR (2005) Regulation of caspase 9 through phosphorylation by protein kinase C zeta in response to hyperosmotic stress. Mol Cell Biol 25: 10543-10555.
127. Sokac AM, Bement WM (2000) Regulation and expression of metazoan unconventional myosins. International Review of Cytology - a Survey of Cell Biology, Vol 200. pp 197-304.
128. Mothes H, Heidet L, Arrondel C, Richter KK, Thiele M, et al. (2002) Alport syndrome associated with diffuse leiomyomatosis: COL4A5-COL4A6 deletion associated with a mild form of Alport nephropathy. Nephrol Dial Transplant 17: 70-74.
129. Colville D, Savige J, Morfis M, Ellis J, Kerr P, et al. (1997) Ocular manifestations of autosomal recessive Alport syndrome. Ophthalmic Genet 18: 119-128.
130. Miki H, Sasaki T, Takai Y, Takenawa T (1998) Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP. Nature 391: 93-96.
131. Wu X, Suetsugu S, Cooper LA, Takenawa T, Guan JL (2004) Focal adhesion kinase regulation of N-WASP subcellular localization and function. J Biol Chem 279: 9565-9576.
132. Suetsugu S, Tezuka T, Morimura T, Hattori M, Mikoshiba K, et al. (2004) Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1. Biochemical Journal 384: 1-8.
133. Goodison S, Urquidi V, Tarin D (1999) CD44 cell adhesion molecules. Mol Pathol 52: 189-196.
134. Wu Q, Maniatis T (1999) A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97: 779-790.
135. Wolfsberg TG, Straight PD, Gerena RL, Huovila APJ, Primakoff P, et, al. (1995) Adam, a Widely Distributed and Developmentally-Regulated Gene Family Encoding Membrane-Proteins with a Disintegrin and Metalloprotease Domain. Developmental Biology 169: 378-383.
136. Wolfsberg TG, Primakoff P, Myles DG, White JM (1995) Adam, a Novel Family of Membrane-Proteins Containing a Disintegrin and Metalloprotease Domain-Multipotential Functions in Cell-Cell and Cell-Matrix Interactions. Journal of Cell Biology 131: 275-278.
137. Horiuchi K, Zhou HM, Kelly K, Manova K, Blobel CP (2005) Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta 1 beta 2. Developmental Biology 283: 459-471.
138. Fambrough D, Pan DJ, Rubin GM, Goodman CS (1996) The cell surface metalloprotease disintegrin Kuzbanian is required for axonal extension in Drosophila. Proceedings of the National Academy of Sciences of the United States of America 93: 13233-13238.
139. Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y, et al. (1995) A metalloprotease-disintegrin participating in myoblast fusion. Nature 377: 652-656.
140. Buxbaum JD, Liu KN, Luo YX, Slack JL, Stocking KL, et al. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amvloid protein precursor. Journal of Biological Chemistry 273: 27765-27767.
141. Endres K, Postina R, Schroeder A, Mueller U, Fahrenholz F (2005) Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metallo-proteinases. Febs J 272: 5808-5820.
142. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang CL, et al. (2003) Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. Embo, Journal 22: 2704-2716.
143. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, et al. (1998) An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284.
144. Zhao J, Chen H, Peschon JJ, Shi W, Zhang Y, et al. (2001) Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev Biol 232: 204-218.
145. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, et al. (2002) Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418: 426-430.
146. Holgate ST, Holloway J, Wilson S, Howarth PH, Haitchi HM, et al. (2006) Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol 117: 496-506; quiz 507.
147. Haitchi HM, Powell RM, Shaw TJ, Howarth PH, Wilson SJ, et al. (2005) ADAM33 expression in asthmatic airways and human embryonic lungs. Am J Respir Crit Care Med 171: 958-965.
148. Tagawa K, Kunishita T, Maruyama K, Yoshikawa K, Kominami E, et al. (1991) Alzheimer's disease amyloid beta-clipping enzyme (APP secretase): identification, purification, and characterization of the enzyme. Biochem Biophys Res Common 177: 377-387.
149. Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, et al. (2002) Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A 99: 7883-7888.
150. Toomes C, James J, Wood AJ, Wu CL, McCormick D, et al. (1999) Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 23: 421-424.
151. Reznik SE, Fricker LD (2001) Carboxypeptidases from A to z: implications in embryonic development and Wnt binding. Cell Mol Life Sci 58: 1790-1804.
152. Liu Y, May NR, Fan CM (2001) Growth arrest specific gene 1 is a positive growth regulator for the cerebellum. Dev Biol 236: 30-45.
153. Brajenovic M, Joberty G, Kuster B, Bouwmeester T, Drewes G (2004) Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem 279: 12804-12811.
154. Wada W, Maeshima. A, Zhang YQ, Hasegawa Y, Kuwano H, et al. (2004) Assessment of the function of the betaC-subunit of activin in cultured hepatocytes. Am J Physiol Endocrinol Metab 287: E247-254.
155. Wada W, Medina J, Hasegawa Y, Kuwano, H, Kojima I (2005) Adenovirus-mediated overexpression of the activin betaC subunit accelerates liver regeneration in partially hepatectomized rats. J Hepatol 43: 823-828.
156. Tasheva ES, Ke A, Deng Y, Jun C, Takemoto LJ, et al. (2004) Differentially expressed genes in the lens of mimecan-null mice. Mol Vis 10: 403-416.
157. Dunlevy JR, Beales MP, Berryhill BL, Cornuet PK, Hassell JR (2000) Expression of the keratan sulfate proteoglycans lumican, keratocan and osteoglycin/mimecan during chick corneal development. Exp Eye Res 70: 349-362.
158. Madisen L, Neubauer M, Plowman G, Rosen D, Segarini P, et al. (1990) Molecular cloning of a novel bone-forming compound: osteoinductive factor. DNA Cell Biol 9: 303-309.
159. Ge G, Seo NS, Liang X, Hopkins DR, Hook M, et al. (2004) Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J Biol Chem 279: 41626-41633.
160. Fang G, Yu H, Kirschner MW (1998) Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol Cell 2: 163-171.
161. Moskovitz J, Weissbach H, Brot N (1996) Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc Natl Acad Sci U S A 93: 2095-2099.
162. Moskovitz J, Jenkins NA, Gilbert DJ, Copeland NG, Jursky F, et al. (1996) Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proceedings of the National Academy of Sciences of the United States of America 93: 3205-3208.
163. Moskovitz J (2005) Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochimica Et Biophysica Acta-Proteins and Proteomics 1703: 213-219.
164. Moskovitz J, Bar-Noy S, Williams WM, Berlett BS, Stadtman ER (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proceedings of the National Academy of Sciences of the United States of America 98: 12920-12925.
165. Levine RL, Moskovitz J, Stadtman ER (2000) Oxidation of methionine in proteins: Roles in antioxidant defense and cellular regulation. Iubmb Life 50: 301-307.
166. Picot CR, Petropoulos I, Perichon M, Moreau M, Nizard C, et al. (2005) Overexpression of MsrA protects WI-38 SV40 human fibroblasts against H2O2-mediated oxidative stress. Free Radic Biol Med 39: 1332-1341.
167. Storz P, Doppler H, Toker A (2005) Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Molecular and Cellular Biology 25: 8520-8530.
168. Laity JH, Lee BM, Wright PE (2001) Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol 11: 39-46.
169. Winston JT, Koepp DM, Zhu CH, Elledge SJ, Harper JW (1999) A family of mammalian F-box proteins. Current Biology 9: 1180-1182.
170. Kuroda H, Takahashi N, Shimada H, Seki M, Shinozaki K, et al. (2002) Classification and expression analysis of Arabidopsis F-box-containing protein genes. Plant and Cell Physiology 43: 1073-1085.
171. Dumstrei K, Nassif C, Abboud G, Aryai A, Aryai A, et al. (1998) EGFR signaling is required for the differentiation and maintenance of neural progenitors along the dorsal midline of the Drosophila embryonic head. Development 125: 3417-3426.
172. Kornblum HI, Hussain R, Wiesen J, Miettinen P, Zurcher SD, et al. (1998) Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J Neurosci Res 53: 697-717.
173. Louvi A, Artavanis-Tsakonas S (2006) Notch signalling in vertebrate neural development. Nat Rev Neurosci 7: 93-102.
174. Voas MG, Rebay I (2004) Signal integration during development: insights from the Drosophila eye. Dev Dyn 229: 162-175.
175. Jump DB, Clarke SD (1999) Regulation of gene expression by dietary fat. Annual Review of Nutrition 19: 63-90.
176. de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, et al. (2000) Docosahexaenoic acid, a ligand for the retinoidxreceptor in mouse brain. Science 290: 2140-2144.
177. Lapillonne A, Clarke SD, Heird WC (2004) Polyunsaturated fatty acids and gene expression. Current Opinion in Clinical Nutrition and Metabolic Care 7: 151-156.
178. Berger A, Mutch DM, German JB, Roberts MA (2002) Unraveling lipid metabolism with microarrays: effects of arachidonate and docosahexaenoate acid on murine hepatic and hippocampal gene expression. Genome Biol 3: PREPRINT0004.
179. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, et al. (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48: 2365-2375.
180. Berger A, Mutch DM, German JB, Roberts MA (2002) Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis 1: 2.
181. Kitajka K, Puskas LG, Zvara A, Hackler L Jr, Barcelo-Coblijn G, et al. (2002) The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci U S A 99: 2619-2624.
182. Barcelo-Coblijn G, Hogyes E, Kitajka K, Puskas LG, Zvara A, et al. (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A 100: 11321-11326.
183. Puskas LG, Kitajka K, Nyakas C, Barcelo-Coblijn G, Farkas T (2003) Shortterm administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci U S A 100: 1580-1585.
184. Seth D, Leo MA, McGuinness PH, Lieber CS, Brennan Y, et al. (2003) Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol 163: 2303-2317.
185. Cox LA, Schlabritz-Loutsevitch N, Hubbard GB, Nijland MJ, McDonald TJ, et al. (2006) Gene expression profile differences in left and right liver lobes from mid-gestation fetal baboons: a cautionary tale. J Physiol 572: 59-66.
186. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
187. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
188. Calvano SE, Xiao WZ, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037.